CHADDS FORD, PA--(Marketwire - April 30, 2008) - Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), a specialty pharmaceutical company with market leadership in pain management, today reported financial results for the three months ended March 31, 2008.
